These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37632645)

  • 1. Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis.
    Bertin H; Moussa MS; Komarova S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1103-1119. PubMed ID: 37632645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
    van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
    Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.
    Florenzano P; Pan KS; Brown SM; Paul SM; Kushner H; Guthrie LC; de Castro LF; Collins MT; Boyce AM
    J Bone Miner Res; 2019 Apr; 34(4):653-660. PubMed ID: 30645769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
    Meier ME; Clerkx SN; Winter EM; Pereira AM; van de Ven AC; van de Sande MAJ; Appelman-Dijkstra NM
    J Bone Miner Res; 2021 Sep; 36(9):1729-1738. PubMed ID: 34076303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate therapy for fibrous dysplasia.
    DiMeglio LA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of developing spontaneous MRONJ in fibrous dysplasia patients treated with bisphosphonates: a systematic review of the literature.
    Nadella S; Mupparapu M; Akintoye SO
    Quintessence Int; 2022 Jun; 53(7):616-623. PubMed ID: 35674165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates.
    Majoor BCJ; Papapoulos SE; Dijkstra PDS; Fiocco M; Hamdy NAT; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6069-6078. PubMed ID: 31390018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.
    Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C
    Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
    Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R
    Bone; 2023 Sep; 174():116819. PubMed ID: 37301527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
    Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.
    Valadares LP; de Araújo Ferreira BS; da Cunha BM; Moreira LA; Batista FGA; da Fonseca Hottz C; Magalhães GGR
    Arch Endocrinol Metab; 2022 Apr; 66(2):247-255. PubMed ID: 35420267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.
    Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.
    Parisi MS; Oliveri MB; Mautalen CA
    J Clin Densitom; 2001; 4(2):167-72. PubMed ID: 11477309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for the treatment of fibrous dysplasia of bone.
    Chapurlat R; Legrand MA
    Bone; 2021 Feb; 143():115784. PubMed ID: 33276154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.
    Rotman M; Hamdy NAT; Appelman-Dijkstra NM
    Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature.
    Ikuta K; Sakai T; Koike H; Ito K; Imagama S; Nishida Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28138. PubMed ID: 34889277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.
    Chapurlat RD; Hugueny P; Delmas PD; Meunier PJ
    Bone; 2004 Jul; 35(1):235-42. PubMed ID: 15207763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications.
    Szymczuk V; Taylor J; Boyce AM
    Curr Osteoporos Rep; 2023 Apr; 21(2):147-153. PubMed ID: 36849642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.